Soleus Capital Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-47,300
Closed -$1.46M 86
2021
Q2
$1.46M Sell
47,300
-32,700
-41% -$979K 0.22% 58
2021
Q1
$2.05M Buy
+80,000
New +$2M 0.37% 51

Other funds holding RNLX

Soleus Capital Management's RNLX Position: Q3 2021 in Review

Soleus Capital Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2021, closing a stake of 47,300 shares — an estimated $1.46M sold.

Soleus Capital Management first reported a position in RNLX in Q1 2021 and held it in 2 quarters. The position peaked at $2.05M in Q1 2021. 31 funds tracked by Wall St. Rank hold RNLX as of Q3 2021.

  • Soleus Capital Management reported no remaining Renalytix plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Soleus Capital Management sold 47,300 Renalytix plc American Depositary Shares shares in Q3 2021, an estimated $1.46M.
  • Soleus Capital Management first reported a position in Renalytix plc American Depositary Shares in Q1 2021 and held it in 2 quarters.
  • Soleus Capital Management's Renalytix plc American Depositary Shares position peaked at $2.05M in Q1 2021.
  • 31 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2021.

Based on Soleus Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.